講演・口頭発表等 - 藤井　靖久

121. Ishioka J et al. Prognostic impact of C-reactive protein kinetics on survival of patients with advanced urothelial carcinoma. A multicenter study. . 米国泌尿器科学会（annual meeting of the American Urological Association） 2016.05.06 San diego, USA

122. Masaharu Inoue, Fumitaka Koga, Soiciro Yoshida, Hajime Tanaka, Shuichiro Kobayashi, Masaya Ito, Minato Yokoyama, Junichiro Ishioka, Yoh Matsuoka, Noboru Numao, Kazutaka Saito, Yasuhisa Fujii, Kazunori Kihara. Prediction of therapeutic resistance using ERBB2 expression status and Ki-67 labeling index in muscle-invasive bladder cancer patients treated with chemoradiation-based selective bladder-sparing approach. the 31st Annual EAU Congress 2016.03.14

123. 4.Kawamura N, Yokoyama M, Fujii Y, Inoue M, Ito M, Yoshida S, Ishioka J, Numao N, Matsuoka Y, Saito K, Kihara K.. Longitudinal preservation of renal function after clamp-less partial nephrectomy: An analysis of patients with chronic kidney disease.. 欧州泌尿器科学会（European Association of Urology annual congress） 2016.03.14 Germany

124. 14.Yasuda Y, Saito K, Kawamura N, Yuasa T, Yokoyama M, Matsuoka Y, Ishioka J, Numao N, Okuno T, Yamamoto S, Takahashi S, Yonese J, Fujii Y, Kihara K. Prognostic significance of early CRP response for metastatic renal cell carcinoma treated with tyrosine kinase inhibitor. 欧州泌尿器科学会（European Association of Urology annual congress） 2016.03.14 Germany

125. Matsuoka Y et al. Impact of PI-RADS version 2 on MRI diagnosis for extracapsular extension of prostate cancer: A multireader study. 欧州泌尿器科学会（European Association of Urology annual congress） 2016.03.14 Germany

126. Inoue M et al. . Prediction of therapeutic resistance using ERBB2 expression status and Ki-67 labelling index in muscle-invasive bladder cancer patients treated with chemoradiation-based selective bladder-sparing approach. . 欧州泌尿器科学会（European Association of Urology annual congress） 2016.03.14 Munich, Germany

127. Yoshida S et al. The utility of diffusion-weighted MRI as an imaging biomarker of upper urinary tract cancer: A preoperative prognostic indicator reflecting histological grade. . 欧州泌尿器科学会（European Association of Urology annual congress） 2016.03.14 Munich, Germany

128. 1.Fujii Y, Kihara K, Tanaka H, Saito K., Yoshida S, Yokoyama M., Ishioka J, Matsuoka Y, Numao N. . Bladder-sparing protocol consisting of ow-dose chemoradiotherapy and consolidative partial cystectomy against muscle-invasive bladder cancer: Oncological and functional outcome in elderly patients.. 欧州泌尿器科学会（European Association of Urology annual congress） 2016.03.13 Germany

129. Nakamura Y et al. Renal dysfunction manifestation in patients with adrenal Cushing's syndrome after adrenalectomy. 欧州泌尿器科学会（European Association of Urology annual congress） 2016.03.13 Munich, Germany

130. 5.Yokoyama M, Kawamura N, Fujii Y, Inoue M, Ishioka J, Numao N, Matsuoka Y, Saito K, Arisawa C, Okuno T, Noro A, Morimoto S, Kihara K. . Longitudinal changes in renal function after radical nephrectomy and risk factors for postoperative severe renal impairment: A Japanese multicenter study using a linear mixed model analysis. 欧州泌尿器科学会（European Association of Urology annual congress） 2016.03.13 Germany

131. Moriyama S et al. A new quantitative method for characterizing small renal masses: MRI intensity ratio curve analysis. 欧州泌尿器科学会（European Association of Urology annual congress） 2016.03.13 Munich, Germany

132. Waseda Y. et al.. Elevation of urinary metanephrine/normetanephrine and impairment of glucose tolerance predict the development of hypoglycemia after resection of pheochromocytoma. 欧州泌尿器科学会（European Association of Urology annual congress） 2016.03.13

133. Ishioka J et al. When should patients undergo prostate biopsy? Decision analysis using differences in the health-related quality-of-life between pre-biopsy healthy men and patients with castration-resistant prostate cancer. . 欧州泌尿器科学会（European Association of Urology annual congress） 2016.03.12 Munich, Germany

134. Fujiwara M et al.. Antibiotic prophylaxis is avoidable in minimally invasive clean surgery for renal or adrenal tumors: A prospective study of 678 cases. Munich, Germany 2016.03.12 Munich, Germany

135. Tanaka H et al. Novel stepwise algorithm using CT and MRI for differential diagnosis of fat-poor angiomyolipoma in small renal masses: Development and external validation. . 欧州泌尿器科学会（European Association of Urology annual congress） 2016.03.12 Munich, Germany

136. Yoshida S et al. . Potential utility of standardized apparent diffusion coefficient value as a biomarker predicting clinical aggressiveness of bladder cancer with various MRI protocols at various institutions. . 欧州泌尿器科学会（European Association of Urology annual congress） 2016.03.12 Munich, Germany

137. Saito K, Matsuoka Y, Numao N, Hayashi K, Yoshida S, Yokoyama M, Ishioka J, Fujii Y, Yoshimura R, Kihara K. Focal therapy for prostate cancer with hemi-gland low dose rate brachytherapy. 8th International Symposium on Focal Therapy and Imaging in Prostate & Kidney Cancer 2015.06.21 Amsterdam

138. Matsuoka Y, Numao N, Saito K, Tanaka H, Ito M, Yoshida S, Yokoyama M, Ishioka J, Fujii Y, Kihara K. Eligibility analysis for focal therapy based on prostatectomy findings: Does intermediate-risk cancer have a higher likelihood of undertreatment than low-risk cancer?. 8th International Symposium on Focal Therapy and Imaging in Prostate & Kidney Cancer 2015.06.21 Amsterdam, Netherland

139. Numao N, Ito M, Yoshida S, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Fujii Y, Kihara K. Efficient sampling methods in systematic biopsy that could be performed in combination with MRI-guided biopsy. 8th International Symposium on Focal Therapy and Imaging in Prostate & Kidney Cancer 2015.06.21 Amsterdam, Netherland

140. 1.Kawamura N., Yokoyama M., Fujii Y., Ishioka J., Numao N., Matsuoka Y., Saito K, Arisawa C., Okuno T., Noro A., Morimoto S., Kihara K. Recovery in renal function after radical nephrectomy and its negative predictive factors: a multicenter longitudinal study. The 111th annual meeting of the American Urological Association 2015.05.18 New Orleans, USA